Biblio Discovery — Demo Discovery Service

3 hasil untuk "Tyler Halladay"

Menampilkan 1–3 · 0,26 detik · RSS

  1. Artikel Jurnal

    Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies

    Yan-Ruide Li; Tyler Halladay; Lili Yang

    Journal of Biomedical Science, Vol. 31 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Cell-based immunotherapies (CBIs), notably exemplified by chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy, have emerged as groundbreaking approaches for cancer therapy. Nevertheless, akin to various other therapeutic modalities, tumor cells employ counterstrategies to…

  2. Artikel Jurnal

    Engineering optimal CAR constructs for allogeneic mesothelin-directed CAR-NKT cells in solid tumor immunotherapy

    Yan-Ruide Li; Yichen Zhu; Tyler Halladay dkk.

    Blood Immunology & Cellular Therapy, Vol. 2 No. 1 · 2026 · Inggris · DOAJ

    Abstract: Chimeric antigen receptor (CAR)–engineered cell therapies have revolutionized cancer immunotherapy and are expanding into other diseases, including autoimmune disorders. Optimizing CAR design, particularly the choice of costimulatory domains and the incorporation of immune-enhancing…

  3. Artikel Jurnal

    Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells

    Yan-Ruide Li; Junhui Hu; Zhe Li dkk.

    Cell Reports Medicine, Vol. 6 No. 9 · 2025 · Inggris · DOAJ Scopus

    Summary: Renal cell carcinoma (RCC) represents about 90% of kidney cancers, with 30%–40% of patients developing metastatic disease despite current treatments. Conventional chimeric antigen receptor (CAR)-T therapy targeting CD70 shows promise but faces challenges due to its autologous, personalized…